ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

29 hedge funds and large institutions have $16.5M invested in Eledon Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
7
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$7K

Top Buyers

1
AC
1
Armistice Capital
New York
$3.94M
2
WP
2
Woodline Partners
California
$1.24M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$155K
4
Citadel Advisors
4
Citadel Advisors
Florida
$41.8K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.25M

Top Sellers

1
CM
1
CM Management
Florida
$252K
2
SFG
2
SVB Financial Group
Texas
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$0
4
CRC
4
Curi RMB Capital
Illinois
$0
5
Northern Trust
5
Northern Trust
Illinois
$71.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$335 +$25 +14 +8%
Group One Trading
27
Group One Trading
Illinois
$40 -$8.78K -4,828 -100%
Bank of America
28
Bank of America
North Carolina
$27 +$27 +15 New
SFG
29
SVB Financial Group
Texas
– -$18.5K -13,472 Closed
Two Sigma Advisers
30
Two Sigma Advisers
New York
– -$17.9K -13,100 Closed
CRC
31
Curi RMB Capital
Illinois
– -$13.7K -10,000 Closed
1
2